Health ❯ Healthcare ❯ Pharmacology

Targeted Therapy

Epidermal Growth Factor Receptor Inhibitors Taletrectinib Camizestrant RAS Inhibitors HER2 Inhibitors Lenvatinib and Everolimus PARP Inhibitors Tucatinib Pan-RAF Inhibitors BRAF Inhibitors HER2-Targeted Agents TROP-2 Dual-Pathway Inhibition T-DXd (Enhertu) Tyrosine Kinase Inhibitors (TKIs)

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

The split votes highlight regulators' push for proof that early treatment changes extend lives.

HER2 Drug Trio Extends Survival in Phase II Study of Breast Cancer Leptomeningeal Metastasis

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.